VolitionRx Limited Cash Equivalents, at Carrying Value
VolitionRx Limited (VNRX) had Cash Equivalents, at Carrying Value of $16.97 million as of 2019-12-31, per its 10-K filed 2020-02-20.
Discontinued › Balance Sheet › Assets › Cash and Cash Equivalent
us-gaap:CashEquivalentsAtCarryingValue · last filed 2020-02-20
- 2019-12-31: Cash Equivalents, at Carrying Value $16.97M.
- 2018-12-31: Cash Equivalents, at Carrying Value $13.43M.
- 2017-12-31: Cash Equivalents, at Carrying Value $10.12M.
| Period end | Cash Equivalents, at Carrying Value |
|---|---|
| 2019-12-31 | $16.97M 10-K · filed 2020-02-20 |
| 2018-12-31 | $13.43M 10-K · filed 2020-02-20 |
| 2017-12-31 | $10.12M 10-K · filed 2020-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |